NORGES BANK - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$15,647,799
-14.4%
770,448
+8.0%
0.00%
-20.0%
Q3 2022$18,287,140
+10.8%
713,227
+2.8%
0.01%
+25.0%
Q2 2022$16,499,159
-6.2%
693,825
-11.1%
0.00%0.0%
Q1 2022$17,581,859
+7.8%
780,722
-5.2%
0.00%
+33.3%
Q4 2021$16,307,000
-23.7%
823,602
-24.2%
0.00%
-40.0%
Q3 2021$21,380,000
+1.4%
1,086,402
+13.3%
0.01%0.0%
Q2 2021$21,091,000
-3.9%
958,675
+3.9%
0.01%0.0%
Q1 2021$21,940,000
-30.4%
922,254
-23.4%
0.01%
-28.6%
Q4 2020$31,510,000
+32.4%
1,204,498
-11.9%
0.01%
+16.7%
Q3 2020$23,805,000
-0.7%
1,367,712
-4.0%
0.01%
-14.3%
Q2 2020$23,975,000
+91.0%
1,425,396
+35.0%
0.01%
+75.0%
Q1 2020$12,550,000
-1.7%
1,055,5070.0%0.00%0.0%
Q4 2019$12,772,000
-14.4%
1,055,5070.0%0.00%
-20.0%
Q3 2019$14,920,000
+53.3%
1,055,507
+20.9%
0.01%
+66.7%
Q2 2019$9,732,000
+17.5%
872,858
+23.8%
0.00%0.0%
Q1 2019$8,280,000
-12.1%
705,3250.0%0.00%
-25.0%
Q4 2018$9,423,000
-4.7%
705,3250.0%0.00%
+33.3%
Q3 2018$9,888,000
+2.1%
705,325
+14.5%
0.00%0.0%
Q2 2018$9,684,000
+23.7%
616,025
+29.5%
0.00%0.0%
Q1 2018$7,826,000475,7610.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders